UnitedHealth Group Incorporated (NYSE:UNH) Shares Acquired by Strategic Investment Advisors MI
Strategic Investment Advisors MI increased its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 121.6% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 4,531 shares of the healthcare conglomerate’s stock after acquiring an additional 2,486 shares during the quarter. Strategic Investment Advisors MI’s holdings in UnitedHealth Group were worth $1,589,000 as of its most recent filing with the SEC.
A number of other hedge funds have also recently added to or reduced their stakes in the business. JJJ Advisors Inc. boosted its position in shares of UnitedHealth Group by 1,820.0% in the third quarter. JJJ Advisors Inc. now owns 96 shares of the healthcare conglomerate’s stock worth $30,000 after acquiring an additional 91 shares during the last quarter. Front Row Advisors LLC grew its stake in shares of UnitedHealth Group by 288.0% during the 3rd quarter. Front Row Advisors LLC now owns 97 shares of the healthcare conglomerate’s stock valued at $33,000 after buying an additional 72 shares during the period. Knuff & Co LLC increased its holdings in shares of UnitedHealth Group by 666.7% during the 3rd quarter. Knuff & Co LLC now owns 115 shares of the healthcare conglomerate’s stock worth $36,000 after buying an additional 100 shares during the last quarter. Old North State Trust LLC purchased a new position in shares of UnitedHealth Group in the 3rd quarter worth $39,000. Finally, Ossiam raised its position in shares of UnitedHealth Group by 42.5% in the 3rd quarter. Ossiam now owns 124 shares of the healthcare conglomerate’s stock worth $39,000 after buying an additional 37 shares during the period. 86.39% of the stock is owned by hedge funds and other institutional investors.
UnitedHealth Group stock traded down $2.33 during mid-day trading on Wednesday, reaching $355.04. The company’s stock had a trading volume of 1,958,265 shares, compared to its average volume of 3,410,015. The company has a current ratio of 0.82, a quick ratio of 0.84 and a debt-to-equity ratio of 0.59. UnitedHealth Group Incorporated has a twelve month low of $187.72 and a twelve month high of $367.95. The business has a 50 day moving average price of $345.34 and a 200-day moving average price of $322.90. The firm has a market cap of $336.87 billion, a price-to-earnings ratio of 20.39, a PEG ratio of 1.53 and a beta of 0.68.
The firm also recently announced a quarterly dividend, which was paid on Tuesday, December 15th. Shareholders of record on Monday, December 7th were issued a $1.25 dividend. The ex-dividend date was Friday, December 4th. This represents a $5.00 dividend on an annualized basis and a yield of 1.41%. UnitedHealth Group’s dividend payout ratio is currently 33.09%.
In related news, Director Stephen J. Hemsley sold 98,579 shares of the business’s stock in a transaction that occurred on Friday, October 23rd. The stock was sold at an average price of $329.47, for a total transaction of $32,478,823.13. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Richard T. Burke sold 7,000 shares of the business’s stock in a transaction that occurred on Tuesday, December 8th. The shares were sold at an average price of $349.78, for a total value of $2,448,460.00. Following the transaction, the director now owns 159,487 shares of the company’s stock, valued at approximately $55,785,362.86. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 130,253 shares of company stock valued at $43,485,730. 0.80% of the stock is currently owned by insiders.
UNH has been the subject of several research analyst reports. UBS Group upped their price target on UnitedHealth Group from $319.00 to $330.00 and gave the stock a “neutral” rating in a research note on Friday, October 16th. BMO Capital Markets raised their target price on shares of UnitedHealth Group from $385.00 to $395.00 and gave the company a “market perform” rating in a research note on Wednesday, December 2nd. They noted that the move was a valuation call. Jefferies Financial Group raised their target price on UnitedHealth Group from $310.00 to $335.00 and gave the company a “hold” rating in a report on Thursday, October 15th. Morgan Stanley lifted their price objective on shares of UnitedHealth Group from $371.00 to $454.00 and gave the company an “overweight” rating in a research note on Wednesday, December 2nd. Finally, Barclays upped their target price on shares of UnitedHealth Group from $322.00 to $365.00 and gave the company an “overweight” rating in a research note on Tuesday, October 13th. Seven analysts have rated the stock with a hold rating, fifteen have assigned a buy rating and one has given a strong buy rating to the company’s stock. The company has an average rating of “Buy” and an average target price of $383.50.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, Children's Health Insurance Program, and health care programs; medical and dental benefits; and health care delivery.
Featured Story: What Is Dividend Yield and How Do You Calculate It?
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.